Evidence map›Paper›PMID 26526183›Full record

ArticleAnnals of clinical microbiology and antimicrobials2015

The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia.

Nadezhda K Fursova, Eugeny I Astashkin, Anastasia I Knyazeva, Nikolay N Kartsev, Ekaterina S Leonova, Olga N Ershova, Irina A Alexandrova, Natalia V Kurdyumova, Svetlana Yu Sazikina, Nikolay V Volozhantsev and 2 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Clinical microbiology reviews · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. OXA-48-like carbapenemases inEmerging microbes & infections · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  17. Article
  18. An Alliance of Carbapenem-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nadezhda K FursovaState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. n-fursova@yandex.ru.
Eugeny I AstashkinState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. ast.ev@mail.ru.
Anastasia I KnyazevaState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. meta-homo@mail.ru.
Nikolay N KartsevState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. karcev.nikolay@mail.ru.
Ekaterina S LeonovaState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. e.leonova@mail.ru.
Olga N ErshovaThe Burdenko Neurosurgery Institute, Moscow, 125047, Russia. oershova@nsi.ru.
Irina A AlexandrovaThe Burdenko Neurosurgery Institute, Moscow, 125047, Russia. ialexandrova@nsi.ru.
Natalia V KurdyumovaThe Burdenko Neurosurgery Institute, Moscow, 125047, Russia. nkurdyumova@nsi.ru.
Svetlana Yu SazikinaThe Burdenko Neurosurgery Institute, Moscow, 125047, Russia. sazikina@nsi.ru.
Nikolay V VolozhantsevState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. nikvol@obolensk.org.
Edward A SvetochState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. svetoch@obolensk.org.
Ivan A DyatlovState Research Center for Applied Microbiology and Biotechnology, Obolensk, 142279, Moscow Region, Russia. dyatlov@obolensk.org.
State Research Center for Applied Microbiology and Biotechnology · RUBurdenko Neurosurgery Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe spread of carbapenemase-producing Enterobacteriaceae (CPE) is a great problem of healthcare worldwide. Study of the spread for bla OXA-48-like genes coding epidemically significant carbapenemases among hospital pathogens is important for the regional and global epidemiology of antimicrobial resistance.

methodsAntibacterial resistant isolates of Klebsiella pneumoniae (n = 95) from 54 patients, P. mirabilis (n = 32) from 20 patients, Enterobacter aerogenes (n = 6) from four patients, and Enterobacter cloacae (n = 4) from four patients were collected from January, 2013 to October, 2014 in neurosurgical intensive care unit (ICU) of the Burdenko Neurosurgery Institute, Moscow. Characteristics of the isolates were done using susceptibility tests, PCR detection of the resistance genes, genotyping, conjugation, DNA sequencing, and bioinformatic analysis.

resultsMajor strains under study were multi drug resistant (MDR), resistant to three or more functional classes of drugs simultaneously-98.9 % K. pneumoniae, 100 % P. mirabilis, one E. aerogenes isolate, and one E. cloacae isolate. Molecular-genetic mechanism of MDR in K. pneumoniae and P. mirabilis isolates were based on carrying of epidemic extended-spectrum beta-lactamase bla CTX-M-15 gene (87.2 and 90.6 % accordingly), carbapenemase bla OXA-48-like gene (55.3 and 23.3 % accordingly), and class 1 (54.8 and 31.3 % accordingly) and class 2 (90.6 % P. mirabilis) integrons. The bla OXA-48-like-positive K. pneumoniae were collected during whole two-year surveillance period, while P. mirabilis and Enterobacter spp. carrying bla OXA-48-like genes were detected only after four and 18 months after the research start, respectively. The bla OXA-48-like gene acquisition was shown for P. mirabilis isolates collected from five patients and for E. cloacae isolate collected from one patient during their stay in the ICU, presumably from bla OXA-48-like-positive K. pneumoniae. The source of the bla OXA-244 gene acquired by E. aerogenes isolates and the time of this event were not recognized.

conclusionsThe expanding of CPE in the surveyed ICU was associated with the spread of bla OXA-48 and bla OXA-244 carbapenemase genes documented not only among K. pneumoniae, well-known bacterial host for such genes, but among P. mirabilis, E. aerogenes, and E. cloacae.

Indexed as

Bacterial Proteinsbeta-LactamasesComputational BiologyConjugation, GeneticDNA, BacterialEnterobacterEnterobacteriaceae InfectionsGenotyping TechniquesHumansIntensive Care UnitsKlebsiella pneumoniaeMolecular Sequence DataMoscowPolymerase Chain ReactionProteus mirabilisSequence Analysis, DNABacterial Proteinsbeta-LactamasescarbapenemaseDNA, Bacterial

Identifiers

PMID26526183
PMCPMC4630924
OpenAlexW1945697742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.